tiprankstipranks
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market

Moleculin Biotech (MBRX) Ownership - Who Owns Moleculin Biotech?

Compare
1,462 Followers

Moleculin Biotech (MBRX) Ownership Overview

2.19%2.26%0.11%0.73%94.71%
0.11% Other Institutional Investors
0.73% ETFs
94.71% Public Companies and Individual Investors
The ownership structure of Moleculin Biotech (MBRX) stock is a mix of institutional, retail, and individual investors. Approximately 3.10% of the company’s stock is owned by Institutional Investors, 2.19% is owned by Insiders, and 94.71% is owned by Public Companies and Individual Investors.
The ownership structure of Moleculin Biotech (MBRX) stock is a mix of institutional, retail, and individual investors. Approximately 2.37% of the company’s stock is owned by Institutional Investors, 2.19% is owned by Insiders, and 0.73% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
72,782Institution1.75%92,433
57,035Insider1.37%72,434
30,314Institution0.73%38,499
21,005Institution0.51%26,676
14,660Insider0.35%18,618
11,363Insider0.27%14,431
8,001Insider0.19%10,161

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
72,782Institution1.75%92,433
21,005Institution0.51%26,676

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
30,314Institution0.73%51,534

FAQ

Who Owns Moleculin Biotech (MBRX)?
According to the latest TipRanks data, approximately 0.11% of the company's stock is held by institutional investors, 2.19% is held by insiders, and 94.71% is held by retail investors.
    What percentage of Moleculin Biotech (MBRX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.11% of Moleculin Biotech (MBRX) stock is held by institutional investors.
      What percentage of Moleculin Biotech (MBRX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 94.71% of Moleculin Biotech (MBRX) stock is held by retail investors.
        Who owns the most shares of Moleculin Biotech (MBRX)?
        VANGUARD INDEX FUNDS owns the most shares of Moleculin Biotech (MBRX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis